Select Publications
Journal articles
, 2026, 'Global perspectives on treatment and harm reduction services for opioid use disorder: Results from an international survey', International Journal of Drug Policy, 156, http://dx.doi.org/10.1016/j.drugpo.2026.105448
, 2026, 'Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70132
, 2025, 'Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market', Harm Reduction Journal, 22, pp. 75, http://dx.doi.org/10.1186/s12954-025-01205-z
, 2025, 'Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia', Drug and Alcohol Review, 44, pp. 1533 - 1542, http://dx.doi.org/10.1111/dar.14092
, 2025, 'Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia', International Journal of Drug Policy, 138, pp. 104749, http://dx.doi.org/10.1016/j.drugpo.2025.104749
, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956
, 2025, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, 120, pp. 1345 - 1359, http://dx.doi.org/10.1111/add.16730
, 2024, 'Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost', BMJ Open, 14, pp. e082553, http://dx.doi.org/10.1136/bmjopen-2023-082553
, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390
, 2024, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', International Journal of Drug Policy, 126, pp. 104383, http://dx.doi.org/10.1016/j.drugpo.2024.104383
, 2024, 'Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study', European Addiction Research, 30, pp. 121 - 125, http://dx.doi.org/10.1159/000536328
, 2023, 'Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review', Psychopharmacology, 240, pp. 127 - 135, http://dx.doi.org/10.1007/s00213-022-06283-6
, 2023, 'Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series', Drug and Alcohol Review, 42, pp. 27 - 32, http://dx.doi.org/10.1111/dar.13556
, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, 241, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692
, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', Plos One, 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371
, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492
, 2022, 'What do General Practitioners want from Specialist Alcohol and Other Drugs Services? A Qualitative Study of NSW Metropolitan GPs', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13463
, 2018, 'Brief interventions for alcohol and other drug use', Australian Prescriber, 41, pp. 117 - 121, http://dx.doi.org/10.18773/AUSTPRESCR.2018.031
, 2018, 'Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies', International Journal of Drug Policy, 55, pp. 165 - 168, http://dx.doi.org/10.1016/j.drugpo.2018.03.020
, 2018, 'An anxious man with codeine dependence: Opioid maintenance therapy', Medicine Today, 19, pp. 35 - 36
, 2016, 'Diagnosis-based emergency department alcohol harm surveillance: What can it tell us about acute alcohol harms at the population level?', Drug and Alcohol Review, pp. n/a - n/a, http://dx.doi.org/10.1111/dar.12458
, 2013, 'Corrigendum to: What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales’ public sexual health services compared with other services?', Sexual Health, 10, pp. 290 - 290, http://dx.doi.org/10.1071/sh12020_co
, 2013, 'What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales’ public sexual health services compared with other services?', Sexual Health, 10, pp. 119 - 123, http://dx.doi.org/10.1071/sh12020
, 2013, 'A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia', Preventive Medicine, Advance online publication, pp. 1 - 7, http://dx.doi.org/10.1016/j.ypmed.2013.04.013
, 2011, 'A RANDOMISED CONTROLLED TRIAL OF CONTINGENCY MANAGEMENT TO INCREASE HEPATITIS B VACCINATION UPTAKE AND COMPLETION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA', DRUG AND ALCOHOL REVIEW, 30, pp. 86 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence', Drug and Alcohol Review, 29, pp. 235 - 242, http://dx.doi.org/10.1111/j.1465-3362.2009.00148.x
, 2010, 'Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status', Drug and Alcohol Dependence, 108, pp. 134 - 137, http://dx.doi.org/10.1016/j.drugalcdep.2009.11.013
, 2009, 'A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence', Addiction, 104, pp. 224 - 233, http://dx.doi.org/10.1111/j.1360-0443.2008.02437.x
, 2008, 'Sexually transmissible infection testing guidelines for men who have sex with men', Sexual Health, 5, pp. 189 - 191